Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Capecitabine and Paclitaxel in Metastatic Breast Cancer
NCT00005649Phase 2Completed
- Sponsor
- Roche
- Start
- Jul 1998
- Primary completion
- Jul 2002
- Modality
- DNA Intercalators/Alkylators, Irreversible Covalent Inhibitors, RNA-Targeting Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of capecitabine in breast cancer, sponsored by Roche. Started Jul 1998; status: completed.
02
Drugs
capecitabine
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00005649.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00005649.